Developer of new drugs from botanical sources, especially anti-cancer and anti-atherosclerosis.

Lead drug is Antroquinonol, derived from Antrodia camphorata, a unique mushroom of Taiwan. IND status granted by US FDA in 2010, with Orphan Drug Designation granted in 2015.

Company has started a fermentation databank with major academic institutions in Taiwan providing fungus strains. Currently, 4000 fungus strains have been screened and stored in this databank.